Contineum Therapeutics(CTNM)
SAN DIEGO, CABiotechnology
Focus: Contineum Therapeutics is a public biotech company focused on small molecule therapeutics for neurology and respiratory indications, headquartered in San Diego.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
3-2 this month
Stable — net -2 jobs in 30d
0 added, 2 removed. Backfill posture.
Should You Work at Contineum Therapeutics?
AI assessmentContineum is a speculative mid-cap bet suitable for risk-tolerant scientists seeking pipeline exposure, but cash runway and minimal hiring warrant due diligence on financing plans.
Why Work Here
- Early-stage pipeline with 8 active trials across high-unmet-need areas (MS, IPF, hearing loss) offers exposure to multiple therapeutic bets
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$50M
Pipeline & Clinical Trials
PIPE-307
Multiple SclerosisClinical Trials (1)
NCT04725175Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers
Phase 1Help build intelligence for Contineum Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.